VeraSci

VeraSci is a privately held company headquartered in Durham, North Carolina. Founded in 2004, the company employs 89 individuals and generates an annual revenue of $51.3 million. VeraSci specializes in providing a comprehensive suite of services to the pharmaceutical industry. Leveraging scientific expertise and innovative technology, VeraSci offers endpoints and clinical outcome assessments, eClinical software solutions, HEOR consulting, and language and translation services. Their client base spans a global reach, supporting pharmaceutical companies in developing novel therapies. VeraSci's eCOA platform, Pathway, is designed to be highly adaptable and cater to the specific requirements of multinational clinical trials of varying magnitudes. VeraSci distinguishes itself through its extensive experience across all phases of drug development, from small-scale phase I studies to large-scale phase III trials involving numerous sites and a vast patient pool. They have a proven track record of providing consulting, site screening, rater training and certification, translation, and data services for over 150 clinical trials conducted in more than 40 countries. For inquiries or more information, interested parties can visit VeraSci's website at verasci.com.